Therefore, our results–namely, concurrent decreases of central BP, arterial reflection, cerebral pulsatilities and plasma NT-proBNP–can be a surrogate evidence that ARB can be a more favourable choice for stroke patients with hypertension. The gene discussed is NPPB; the disease is hypertensive disorder.